LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lifeline for cancer patients: study extends access to vital drug
Disease control OngoingThis study provides continued access to the cancer drug ibrutinib for patients who have finished a previous ibrutinib trial, are still benefiting from it, but cannot get it through regular commercial channels. It allows them to keep taking the drug while researchers collect long-…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE4 • Sponsor: Pharmacyclics Switzerland GmbH • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists track patients for 15 years after revolutionary cancer treatment
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows people for up to 15 years after they received CAR T-cell gene therapy for blood cancers like lymphoma and leukemia. Researchers check in annually through clinic visits, phone calls, or emails to monitor for any long-term side effects or health issues. The study…
Matched conditions: LEUKEMIA, B-CELL
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC